Clinical Trials on Narcotic Consumption in United Kingdom

Total 1245 results

University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dose Alteration Study - 1

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
Montefiore Medical Center

Recruiting

Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery

Pain, Postoperative | Narcotic Use

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Not yet recruiting

Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers

Alcohol Consumption | Alcohol Use Disorder (AUD) | Heavy Drinker

United States
Washington University School of Medicine

Recruiting

Improving Health and Employment Outcomes Through Workplace Opioid Policies

Opioid-Related Disorders

United States
Biomedical Development Corporation
National Institute on Drug Abuse (NIDA); The University of Texas Health Science...

Active, not recruiting

Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder (KIOS-I)

Opioid-Related Disorders

United States
Duke University
Alkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources... and other collaborators

Completed

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings (DC)

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Clinical Rescue Protocol - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 2 - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 5 - 5

Opioid-Related Disorders

United States
Butler Hospital

Completed

Interactive Voice Response (IVR) for Methadone Patients

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
West Virginia University
National Institute on Drug Abuse (NIDA); Medtronic

Active, not recruiting

Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder (DBS_OUD)

Opioid-Related Disorders

United States
University of Michigan
Centers for Disease Control and Prevention

Completed

The OPT-IN Project

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Protocol - 1

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Clinical Trial of Buprenorphine - 3

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 4 - 4

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 1 - 1

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
Member Companies of the Opioid PMR Consortium
Kaiser Permanente; Kaiser Permanente Washington

Active, not recruiting

A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse

United States
National Institute on Drug Abuse (NIDA)
Washington D.C. Veterans Affairs Medical Center

Completed

Activity Monitoring Assessment of Opiate Withdrawal - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Washington D.C. Veterans Affairs Medical Center

Completed

Comparison of Buprenorphine and Methadone - 3

Opioid-Related Disorders

United States
University of Washington
National Institute on Drug Abuse (NIDA); emocha Mobile Health, Inc.

Completed

Trial of Adherence App for Buprenorphine Treatment (TAAB) Study

Opioid-Related Disorders

United States
Acura Pharmaceuticals Inc.

Completed

Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users

Opioid-Related Disorders

United States
Ohio State University

Completed

Novel Multimodal Pain Control Protocol for Minimally Invasive Gynecologic Surgery

Postoperative Pain | Cryotherapy Effect | Narcotic Use

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

Opioid Dependence Treatment Therapies in Pregnancy

Pregnancy | Opioid-Related Disorders

United States
Indivior Inc.

Completed

Safety and Tolerability of Buprenorphine/Naloxone Film Strips

Opioid-Related Disorders

United States
Member Companies of the Opioid PMR Consortium

Terminated

Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse

United States
National Institute on Drug Abuse (NIDA)
Britannia Pharmaceuticals Ltd.

Completed

Lofexidine for Opiate Withdrawal - 1

Opioid-Related Disorders

United States
Ying Liu
Avanos Medical

Recruiting

Intraperitoneal Infusion of Analgesic for Postoperative Pain Management (ON-Q)

Pain, Postoperative | Hysterectomy | Narcotic Use | Gynecologic Surgical Procedures

United States
University of Southern California
Northwestern University; National Institute on Aging (NIA); AltaMed Health Services...

Completed

AESOPS Trial 2 (AESOPS-2): Availability of Opioid Harm (AESOPS-2)

Opioid Abuse

United States
Emory University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Community Trial in the Cherokee Nation

Opioid Abuse

United States
University of Wisconsin, Madison

Completed

Dane County Drug Court Study for Addicted Offenders

Opioid Dependence

United States
New York State Psychiatric Institute
Alkermes, Inc.

Terminated

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Heroin Dependence

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry (XOR)

Opioid-Related Disorders | Heroin Dependence

United States
University of Pennsylvania
Patient-Centered Outcomes Research Institute

Completed

Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone (OAPXRNTX)

Opiate Dependence

United States
NYU Langone Health

Withdrawn

Needle-X: Usability Testing of a Smartphone Application

Opioid Dependence

United States
University of Alabama at Birmingham

Withdrawn

Comparison of Three Opioid Detoxification Treatment Regimens

Opioid-Related Disorders | Opioid Withdrawal

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Depot Naltrexone Treatment of Opioid Dependent Parolees

Opioid Dependence

United States

Clinical Trials on Narcotic Consumption in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations